e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aditxt, Inc. - Common Stock
(NQ:
ADTX
)
0.8404
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aditxt, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
21
22
Next >
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By Around 38%; Here Are 20 Stocks Moving Premarket
↗
April 24, 2023
Gainers ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA) gained 118% to $3.64 in pre-market trading after declining around 5% on Friday. ZyVersa Therapeutics recently posted a wider FY loss.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
April 21, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
April 21, 2023
Via
Benzinga
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
April 21, 2023
Via
Investor Brand Network
Why Sidus Space Shares Are Trading Lower By Around 24%; Here Are 20 Stocks Moving Premarket
↗
April 21, 2023
Gainers Wang & Lee Group, Inc. (NASDAQ: WLGS) jumped 266.1% to $11.35 in pre-market trading after dropping 38% on Thursday. WANG & LEE GROUP priced its initial public offering of 1,600,000 shares at a...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
April 21, 2023
It's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday!
Via
InvestorPlace
Why Aditxt Shares Are Surging Today
↗
April 20, 2023
Aditxt, Inc. (NASDAQ: ADTX) stock is surging Thursday as it expands its portfolio to include innovative therapies for infectious diseases.
Via
Benzinga
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 20, 2023
Via
Benzinga
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
April 20, 2023
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...
Via
Benzinga
Crude Oil Down 2%; AT&T Shares Plunge After Q1 Results
↗
April 20, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday. The Dow traded down 0.26% to 33,809.22 while the NASDAQ fell 0.43% to 12,104.71. The...
Via
Benzinga
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Inks Asset Purchase Agreement for 50% Ownership of Global Response Aid
April 20, 2023
Via
Investor Brand Network
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Allergic Reactions Caused by Gel Nail Polishes on the Rise
April 19, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans
April 17, 2023
Via
Investor Brand Network
Aditxt Issues Shareholder Update
April 17, 2023
From
Aditxt, Inc.
Via
Business Wire
US Federal Agency Plans to Overhaul Organ Transplant Network
April 13, 2023
Via
Investor Brand Network
Study Describes Link Between Viral infections, Autoimmune Diseases
April 06, 2023
Via
Investor Brand Network
Study Suggests Giving Babies Peanut Butter Cuts Allergy Risk
March 31, 2023
Via
Investor Brand Network
Debate Rages Regarding Patients Listing on Multiple Organ Transplant Wait Lists
March 27, 2023
Via
Investor Brand Network
Researchers ID Substance That Could Make Autoimmune Disease Treatment Possible
March 21, 2023
Via
Investor Brand Network
How Research on Blood Cancer Could Benefit the Organ Transplant Field
March 15, 2023
Via
Investor Brand Network
FDA Issues Warning about Reliability of Food Allergy Skin Tests
March 08, 2023
Via
Investor Brand Network
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Veteran of Media Industry as Chief Content, Engagement Officer
March 08, 2023
Via
Investor Brand Network
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
March 08, 2023
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
March 03, 2023
Via
Investor Brand Network
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.
March 03, 2023
From
Aditxt, Inc.
Via
Business Wire
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.